Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.
Saved in:
| Title: | Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults. |
|---|---|
| Authors: | Prasert K; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand., Nakphook S; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand., Kittiwatanachod J; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand., Sornwong K; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand., Naosri S; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand., Ongarj P; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand., Techatanawat I; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand., Narakorn P; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand., Surichan S; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand., Flores J; PATH, Seattle, WA 98103, USA., Mercer LD; PATH, Seattle, WA 98103, USA., Polyak CS; PATH, Seattle, WA 98103, USA., Innis BL; PATH, Seattle, WA 98103, USA., Raghunandan R; PATH, Seattle, WA 98103, USA., Pittayawonganon C; Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi 11000, Thailand., Iamsirithaworn S; Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi 11000, Thailand., Sirilak S; Health Systems Research Institute, Nonthaburi 11000, Thailand., Wirachwong P; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand., Praphasiri P; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand. |
| Source: | Vaccines [Vaccines (Basel)] 2026 May 28; Vol. 14 (6). Date of Electronic Publication: 2026 May 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42347602 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Prasert+K%22">Prasert K</searchLink>; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.<br /><searchLink fieldCode="AU" term="%22Nakphook+S%22">Nakphook S</searchLink>; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand.<br /><searchLink fieldCode="AU" term="%22Kittiwatanachod+J%22">Kittiwatanachod J</searchLink>; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.<br /><searchLink fieldCode="AU" term="%22Sornwong+K%22">Sornwong K</searchLink>; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand.<br /><searchLink fieldCode="AU" term="%22Naosri+S%22">Naosri S</searchLink>; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand.<br /><searchLink fieldCode="AU" term="%22Ongarj+P%22">Ongarj P</searchLink>; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand.<br /><searchLink fieldCode="AU" term="%22Techatanawat+I%22">Techatanawat I</searchLink>; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand.<br /><searchLink fieldCode="AU" term="%22Narakorn+P%22">Narakorn P</searchLink>; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand.<br /><searchLink fieldCode="AU" term="%22Surichan+S%22">Surichan S</searchLink>; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand.<br /><searchLink fieldCode="AU" term="%22Flores+J%22">Flores J</searchLink>; PATH, Seattle, WA 98103, USA.<br /><searchLink fieldCode="AU" term="%22Mercer+LD%22">Mercer LD</searchLink>; PATH, Seattle, WA 98103, USA.<br /><searchLink fieldCode="AU" term="%22Polyak+CS%22">Polyak CS</searchLink>; PATH, Seattle, WA 98103, USA.<br /><searchLink fieldCode="AU" term="%22Innis+BL%22">Innis BL</searchLink>; PATH, Seattle, WA 98103, USA.<br /><searchLink fieldCode="AU" term="%22Raghunandan+R%22">Raghunandan R</searchLink>; PATH, Seattle, WA 98103, USA.<br /><searchLink fieldCode="AU" term="%22Pittayawonganon+C%22">Pittayawonganon C</searchLink>; Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi 11000, Thailand.<br /><searchLink fieldCode="AU" term="%22Iamsirithaworn+S%22">Iamsirithaworn S</searchLink>; Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi 11000, Thailand.<br /><searchLink fieldCode="AU" term="%22Sirilak+S%22">Sirilak S</searchLink>; Health Systems Research Institute, Nonthaburi 11000, Thailand.<br /><searchLink fieldCode="AU" term="%22Wirachwong+P%22">Wirachwong P</searchLink>; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand.<br /><searchLink fieldCode="AU" term="%22Praphasiri+P%22">Praphasiri P</searchLink>; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101629355%22">Vaccines</searchLink> [Vaccines (Basel)] 2026 May 28; Vol. 14 (6). <i>Date of Electronic Publication: </i>2026 May 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101629355 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2076-393X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222076393X%22">2076393X </searchLink><i>NLM ISO Abbreviation: </i>Vaccines (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42347602 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/vaccines14060481 Languages: – Code: eng Text: English Titles: – TitleFull: Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Prasert K – PersonEntity: Name: NameFull: Nakphook S – PersonEntity: Name: NameFull: Kittiwatanachod J – PersonEntity: Name: NameFull: Sornwong K – PersonEntity: Name: NameFull: Naosri S – PersonEntity: Name: NameFull: Ongarj P – PersonEntity: Name: NameFull: Techatanawat I – PersonEntity: Name: NameFull: Narakorn P – PersonEntity: Name: NameFull: Surichan S – PersonEntity: Name: NameFull: Flores J – PersonEntity: Name: NameFull: Mercer LD – PersonEntity: Name: NameFull: Polyak CS – PersonEntity: Name: NameFull: Innis BL – PersonEntity: Name: NameFull: Raghunandan R – PersonEntity: Name: NameFull: Pittayawonganon C – PersonEntity: Name: NameFull: Iamsirithaworn S – PersonEntity: Name: NameFull: Sirilak S – PersonEntity: Name: NameFull: Wirachwong P – PersonEntity: Name: NameFull: Praphasiri P IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 05 Text: 2026 May 28 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2076-393X Numbering: – Type: volume Value: 14 – Type: issue Value: 6 Titles: – TitleFull: Vaccines Type: main |
| ResultId | 1 |